Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration

The application of autologous mesenchymal stem cells (MSC) for the treatment of bone defects requires two invasive procedures and several weeks of ex vivo cell expansion. To overcome these limitations, the administration of allogeneic MSC may be attractive, because they are anticipated to be immunop...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Rapp, Anna E., Bindl, Ronny, Erbacher, Annika, Kruchen, Anne, Rojewski, Markus, Schrezenmeier, Hubert, Müller, Ingo, Ignatius, Anita
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6163925/
https://ncbi.nlm.nih.gov/pubmed/30149650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19092526
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares